ANDA 202951, held by Avet Lifesciences. Palonosetron Hydrochloride.
As of Nov 16, 2026, ANDA 202951 (Palonosetron Hydrochloride), held by Avet Lifesciences, was first approved by FDA on Jun 29, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 29, 2021 | Original application | Approved | None posted |
| Palonosetron HydrochlorideEQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) · injectable;intravenous | Palonosetron Hydrochloride | Rx |
| Palonosetron HydrochlorideEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) · injectable;intravenous | Palonosetron Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters